Literature DB >> 27443

G6PD Vientiane: a new glucose-6-phosphate dehydrogenase variant with increased stability.

A Kahn, M L North, D Cottreau, G Giron, J M Lang, F Oberling.   

Abstract

A new G6PD variant, called G6PD Vientiane, has been discovered in a patient from Laos. The characteristics of this variant are: mild enzyme deficiency (about 50% of the normal activity) in the granulocytes and the red cells, with normal G6PD-related antigen concentration; increased stability; normal Km glucose 6-phosphate and NADP+; increased inhibition constant by NADPH; decreased inhibition by ATP; slightly increased utilization of the substrate analogue; abnormal pH curve, with maximum activity at pH 9.5; slightly reduced starch gel electrophoretic migration. The implications of the molecular stability of a deficient mutant variant are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27443     DOI: 10.1007/BF00396482

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  GD (--) Aachen, a new variant of deficient glucose-6-phosphate dehydrogenase. Clinical, genetic, biochemical aspects.

Authors:  A Kahn; A Esters; M Habedank
Journal:  Hum Genet       Date:  1976-05-19       Impact factor: 4.132

2.  Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.

Authors:  J E May; W Rosse; M M Frank
Journal:  N Engl J Med       Date:  1973-10-04       Impact factor: 91.245

3.  Human glucose-6-phosphate dehydrogenase variants: a supplementary tabulation.

Authors:  E Beutler; A Yoshida
Journal:  Ann Hum Genet       Date:  1973-10       Impact factor: 1.670

4.  Human glucose-6-phosphate dehydrogenase variants.

Authors:  A Yoshida; E Beutler; A G Motulsky
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

5.  In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency.

Authors:  S Piomelli; L M Corash; D D Davenport; J Miraglia; E L Amorosi
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

6.  Hereditary erythrocyte pyruvate kinase deficiency: molecular and functional studies of four mutant PK variants detected in Spain.

Authors:  J Marie; J L Vives-Corrons; A Kahn; B Kernemp
Journal:  Clin Chim Acta       Date:  1977-12-01       Impact factor: 3.786

7.  Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency.

Authors:  A Kahn; D Cottreau; P Boivin
Journal:  Humangenetik       Date:  1974

8.  Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.

Authors:  O Götze; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1972-01-27       Impact factor: 91.245

9.  Hemolytic anemia and G6PD deficiency.

Authors:  A Yoshida
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

10.  A Spanish family with erythrocyte pyruvate kinase deficiency: contribution of various immunologic methods in the study of the mutant enzyme.

Authors:  A Kahn; J L Vives-Corron; J Marie; C Galand; P Boivin
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

View more
  2 in total

1.  Variants of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) in Bulgarian populations.

Authors:  T L Shatskaya; K D Krasnopolskaya; M Tzoneva; M Mavrudieva; D Toncheva
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

2.  Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.

Authors:  Ken Ing Cherng Ong; Hodaka Kosugi; Sophea Thoeun; Hitomi Araki; Moe Moe Thandar; Moritoshi Iwagami; Bouasy Hongvanthong; Paul T Brey; Shigeyuki Kano; Masamine Jimba
Journal:  BMJ Glob Health       Date:  2017-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.